Zobrazeno 1 - 10
of 37
pro vyhledávání: '"EuroSIDA in EuroCOORD"'
Autor:
Maria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, Marc Noguera-Julian, Markus Bickel, Dalibor Sedlacek, Kai Zilmer, Bonaventura Clotet, Jens D Lundgren, Roger Paredes, EuroSIDA in EuroCOORD
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0166613 (2017)
OBJECTIVETo investigate if plasma HIV-1 tropism testing could identify subjects at higher risk for clinical progression and death in routine clinical management.DESIGNNested case-control study within the EuroSIDA cohort.METHODSCases were subjects wit
Externí odkaz:
https://doaj.org/article/1c762a07324c46afa09a1e21d4306f35
Autor:
Alexander Zoufaly, Alessandro Cozzi-Lepri, Joanne Reekie, Ole Kirk, Jens Lundgren, Peter Reiss, Djordje Jevtovic, Ladislav Machala, Robert Zangerle, Amanda Mocroft, Jan Van Lunzen, EuroSIDA in EuroCoord
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87160 (2014)
BACKGROUND: The impact of immunosuppression despite virological suppression (immuno-virological discordance, ID) on the risk of developing fatal and non-fatal AIDS/non-AIDS events is unclear and remains to be elucidated. METHODS: Patients in EuroSIDA
Externí odkaz:
https://doaj.org/article/c0638688d5e94bb7bd85b5c62232f4f4
Autor:
Joanne Reekie, Justyna D Kowalska, Igor Karpov, Jurgen Rockstroh, Anders Karlsson, Aza Rakhmanova, Andrzej Horban, Ole Kirk, Jens D Lundgren, Amanda Mocroft, EuroSIDA in EuroCoord
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41673 (2012)
BACKGROUND: Differences in access to care and treatment have been reported in Eastern Europe, a region with one of the fastest growing HIV epidemics, compared to the rest of Europe. This analysis aimed to establish whether there are regional differen
Externí odkaz:
https://doaj.org/article/69dabc54889e41f1ae0a3e6b852613bf
Autor:
EuroSIDA in EuroCOORD, Shepherd, L.1, Mocroft, A.1, Bogner, J. R.2, Gargalianos‐Kakolyris, P.3, Mussini, C.4, Mansinho, K.5, Yust, I.6, Paduta, D.7, Jilich, D.8, Smiatacz, T.9, Radoi, R.10, Tomazic, J.11, Borges, ÁH12, Lundgren, J.12, Plomgaard, P.13, Frikke‐Schmidt, R.13, Harvey, R.14, Bower, M.14, Grulich, A.14
Publikováno v:
HIV Medicine. Feb2018, Vol. 19 Issue 2, p90-101. 12p.
Autor:
Podlekareva D, Grint D, Karpov I, Vassilenko A, Rakmanova A, Mansinho K, Chentsova N, Kravchenko E, Zeltina I, Losso M, Parczewski M, Lundgren J, Mocroft A, Kirk O, EuroSIDA in EuroCoorD, Lazzarin Adriano, Castagna Antonella
Objectives: The long-term side effects of stavudine (d4T) led to recommendations in 2009 to phase out use of this drug. We aimed to describe temporal patterns of d4T use across Europe. Methods: Patients taking combination antiretroviral therapy (cART
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::9844dbdad123a453d72f3fe92f449b7a
http://www.wiley.com/bw/journal.asp?ref=1464-2662
http://www.wiley.com/bw/journal.asp?ref=1464-2662
Autor:
Borges, Ãlvaro H., Lundgren, Jens D., Ridolfo, Annalisa, Katlama, Christine, Antunes, Francisco, Grzeszczuk, Anna, Blaxhult, Anders, Mitsura, Viktar M., Doroana, Manuela, Battegay, Manuel, Gargalianos, Panagiotis, Mocroft, Amanda, Eurosida In Eurocoord, CASTAGNA, ANTONELLA
Publikováno v:
AIDS (London, England), 28(17), 2565-2571. Lippincott Williams and Wilkins
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Objective: To assess the relationship between platelet counts and risk of AIDS and non-AIDS-defining events. Design: Prospective cohort. Methods: EuroSIDA patients with at l
Objective: To assess the relationship between platelet counts and risk of AIDS and non-AIDS-defining events. Design: Prospective cohort. Methods: EuroSIDA patients with at l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b66a2dd4fafe4a66864b99cb8d6b23c0
http://www.AIDSonline.com
http://www.AIDSonline.com
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
Autor:
Mocroft, A, Reiss, P, Rakhmanova, A, Banhegyi, D, Phillips, AN, De Wit, S, Ristola, M, Lundgren, JD, Grarup, J, Kirk, O, EuroSIDA in EuroCOORD, for, Vandekerckhove, Linos
Publikováno v:
Infection, 42, 757-62
Infection, 42, 4, pp. 757-62
INFECTION
Infection, 42, 4, pp. 757-62
INFECTION
Item does not contain fulltext ATRIPLA is licensed for use only in HIV-positive persons whose viral loads /= 3 months. We investigated the use of ATRIPLA as first-line antiretroviral therapy (ART) in EuroSIDA using a web-based survey performed in Aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7fdfcba83e25151a7930e7ad693476fa
Autor:
Gitte Kronborg, Andrew E. Grulich, EuroSIDA in EuroCOORD, Leah Shepherd, Mark Bower, Richard J. Harvey, Massimo Galli, Michael J. Silverberg, Ole Kirk, Lene Ravn, Álvaro H. Borges, Amanda Mocroft, Jens D Lundgren
Background It is common practice to use prostate specific antigen (PSA) ≥4.0 ng/ml as a clinical indicator for men at risk of prostate cancer (PCa), however, this is unverified in HIV+ men. We aimed to describe kinetics and predictive value of PSA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71c965e7099e0af77b651bc79ebc33c
http://hdl.handle.net/10044/1/49493
http://hdl.handle.net/10044/1/49493
Objectives: To evaluate and compare the performance of six HIV-RNA-based quality of care indicators for predicting short-term and long-term outcomes. Design: Multinational cohort study. Methods: We included EuroSIDA patients on antiretroviral therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::f30b2e25698116b94488c6fc78999311
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3001387
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3001387
Autor:
Galyna A Kutsyna, Fiona Burns, Jens D Lundgren, Cristina Mussini, EuroSIDA in EuroCOORD, S De Wit, Court Pedersen, Maryam Shahmanesh, Amanda Mocroft, Anna Schultze, Ole Kirk
Publikováno v:
Shahmanesh, M, Schultze, A, Burns, F, Kirk, O, Lundgren, J, Mussini, C, Pedersen, C, De Wit, S, Kutsyna, G, Mocroft, A & EuroSIDA in EuroCoord 2016, ' The cardiovascular risk management for people living with HIV in Europe : how well are we doing? ', AIDS, vol. 30, no. 16, pp. 2505-2518 . https://doi.org/10.1097/QAD.0000000000001207
Objectives: HIV has become a chronic condition associated with comorbidities. We investigated cardiovascular risk and risk modification in a European HIV cohort. Methods: EuroSIDA patients (from 1 January 2000) for whom cardiovascular risk could be c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389d3544a27e58116c84a7db510ad480
https://hdl.handle.net/11380/1219804
https://hdl.handle.net/11380/1219804